OxLDL induces mitogen-activated protein kinase activation mediated via PI3-kinase/Akt in vascular smooth muscle cells

Journal of Lipid Research

Volumn 44, Issue 9, 2003, Pages 1667-1675

  Chien, Ming Wei ^a   Chien, Chin Sung ^a   Hsiao, Li Der ^a   Lin, Ching Hsuan ^a   Yang, Chuen Mao ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Ca 2+; DNA synthesis; Epidermal growth factor; Oxidized LDL; Phosphatidylinositol 3 kinase; Protein kinase C

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; CHOLERA TOXIN; EDETIC ACID; EPIDERMAL GROWTH FACTOR; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; LIPID OXIDATION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CALCIUM; CELLS, CULTURED; CHOLERA TOXIN; ENZYME ACTIVATION; FORSKOLIN; HUMANS; LIPOPROTEINS, LDL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PERTUSSIS TOXIN; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; TRANSCRIPTION FACTORS;

EID: 0141794271     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300006-JLR200     Document Type: Article

References (46)

1. Steinberg, D. 1997. A critical look at the evidence for the oxidation of LDL in atherogenesis. Atherosclerosis. 131(Suppl.): 5-7.
2. Mertens, A., and P. Holvoet. 2001. Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J. 15: 2073-2084.
3. Cushing, S. D., J. A. Berliner, A. J. Valene, M. C. Territo, M. Navab, F. Parhami, R. Gerrity, C. J. Schartz, and A. M. Fogelman. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein I in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87: 5134-5138.
4. Newby, A. C., and S. J. George. 1996. Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis. Curr. Opin. Cardiol. 11: 574-582.
5. Kockx, M. M. 1998. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 18: 1519-1522.
6. Heermeier, K., W. Leicht, A. Palmetshofer, M. Ullrich, C. Wanner, and J. Galle. 2001. Oxidized LDL suppresses NF-kappaB and overcomes protection from apoptosis in activated endothelial cells. J. Am. Soc. Nephrol. 12: 456-463.
7. Yang, C. M., C. T. Chiu, C. C. Wang, C. S. Chien, L. D. Hsiao, C. C. Lin, M. T. Tu, and S. L. Pan. 2000. Activation of mitogen-activated protein kinase by oxidized low-density lipoprotein in canine cultured vascular smooth muscle cells. Cell. Signal. 12: 205-214.
8. Yang, C. M., C. S. Chien, L. D. Hsiao, S. L. Pan, C. C. Wang, C. T. Chiu, and C. C. Lin. 2001. Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway. Br J. Pharmacol. 132: 1531-1541.
9. Sachinidis, A., S. Seewald, P. Epping, C. Seul, Y. Ko, and H. Vetter. 1997. The growth-promoting effect of low-density lipoprotein may be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway. Mol. Pharmacol. 52: 389-397.
10. Stiko-Rahm, A., A. Hultgardh-Niosson, J. Regnscrom, A. Hamsten, and J. Nilsson. 1992. Native and oxidized LDL enhances production of PDGF-AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscler. Thromb. 12: 1099-1109.
11. Boulanger, C. M., F. C. Tanner, M. L. B'ca, A. W. Hahn, A. Werner, and T. F. Luscher. 1992. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Cir. Res. 70: 1191-1197.
12. Martens, J. S., N. E. Reiner, P. Herrera-Velit, and U. P. Steinbrecher. 1998. Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein. J. Biol. Chem. 273: 4915-4920.
13. Berry, C., R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns. 2001. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am. J. Physiol. 281: H2337-H2365.
14. Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. K. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. 1995. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736.
15. Franke, T. F., D. R. Kaplan, L. C. Cantley, and A. Toker. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 275: 665-668.
16. 44 mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells. Glycobiology. 7: 702-710.
17. Downward, J. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10: 262-267.
18. Hu, Q., A. Klippel, A. J. Muslin, W. J. Fantl, and L. T. Williams. 1995. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science. 268: 100-102.
19. Duckworth, B. C., and L. C. Cantley. 1997. Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin: dependence on signal strength. J. Biol. Chem. 272: 27665-27670.
20. King, W. G., M. D. Mattalino, T. O. Chan, P. N. Tsichlis, and J. S. Brugge. 1997. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol. Cell. Biol. 17: 4406-4418.
21. Chan, T. O., S. E. Rittenhouse, and P. N. Tsichlis. 1999. AkT/PKB and other D3 phosphoinositide regulated kinases: kinase activation by phosphoinositide-dependent phosphorylations. Annu. Rev. Biochem. 68: 965-1014.
22. Vanhaescbroeck, B., and D. R. Alessi. 2000. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346: 561-576.
23. Biwa, T., M. Sakai, T. Matsumura, S. Kobori, K. Kaneko, A. Miyazaki, H. Hakamata, S. Horiuchi, and M. Shichiri. 2000. Sites of action of protein kinase C and phosphatidylinositol 3-kinase are distinct in oxidized low density lipoprotein-induced macrophage proliferation. J. Biol. Chem. 275: 5810-5816.
24. Hundal, R. S., B. S. Salh, J. W. Schrader, A. Gomez-Munoz, V. Duronio, and U. P. Steinbrecher. 2001. Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI3-kinase/PKB pathway. J. Lipid Res. 42: 1483-1491.
25. Olofsson, S-O., K. Bosrom, U. Svanberg, and G. Bonjers. 1980. Isolation and partial characterization of polypeptide belonging to apolipoprotein B from low density lipoproteins in human plasma. Biochemistry. 19: 1059-1064.
26. Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witzum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81: 3883-3887.
27. Morel, D. W., P. E. Dicorleto, and G. M. Chisolm. 1984. Endothelial and smooth muscle cells alter LDL in vitro by free radical oxidation. Arteriosclerosis. 4: 357-364.
28. Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-I. EMBO J. 15: 6541-6551.
29. Kim, S., K. Jee, D. Kim, H. Koh, and J. Chung. 2001. Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1. J. Biol. Chem. 276: 12864-12870.
30. Scott, P. H., C. M. Belham, J. Al-Hafidh, E. R. Chilvers, A. J. Peacock, G. W. Gould, and R. Plevin. 1996. A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells. Biochem. J. 318: 965-971.
31. Reisink, T. J., V. A. Tkachuk, J. Berrhardt, and F. R. Buhler. 1992. Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells. Arterioscler. Thromb. 2: 278-285.
32. Weisser, B., R. Locher, T. Mengden, and W. Vetter. 1992. Oxidation of low density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular-smooth muscle cells. Arterioscler. Thromb. 12: 231-236.
33. Cuevas, B. D., Y. Lu, M. Mao, J. Zhang, R. LaPushin, K. Siminovitch, and G. B. Mills. 2001. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 276: 27455-27461.
34. Rojntickarin, P., Y. Miyakawa, N. E. Fox, J. Deou, G. Daum, and K. Kaushansky. 2001. The roles of phosphatidylinositol 3-kinase and protein kinase Cζ for thrombopoietin-induced mitogen-activated protein kinase activation in primary murine megakaryocytes. J. Biol. Chem. 276: 41014-41022.
35. Li, D. Y., H. J. Chen, and J. L. Mehta. 2001. Statins inhibit oxidized LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc. Res. 52:130-135.
36. Hawes, B. E., L. M. Luttrelf, T. van Biesen, and R. J. Lefkowitz. 1996. Phosphatidylinositol 3-kinase is an early intermediate in the Gβγ-mediated mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 271: 12133-12136.
37. Leopold, D., T. Hanck, T. Exner, U. Maier, R. Wetzker, and B. Nurnberg. 1998. Gβγ stimulates phosphoinositide 3-kinase-γ by direct interaction with two domains of the catalytic p110 subunit. J. Biol. Chem. 273: 7024-7029.
38. Lopez-Illasaca, M., P. Crespo, P. G. Pellici, J. S. Gutkind, and R. Wetzken. 1997. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI3-kinase gamma. Science. 275: 394-397.
39. Datta, S. R., A. Brunet, and M. E. Grcenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13: 2905-2927.
40. Crespo, P., T. G. Cachero, N. Xu, and J. S. Gutkind. 1995. Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway. J. Biol. Chem. 270: 25259-25265.
41. Natarajan, V. J., W. M. Scaribner, C. M. Hart, and S. Parthasarathy. 1995. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J. Lipid Res. 36: 2005-2015.
42. Andjelkovic, M., T. Jakubwicz, P. Cron, X. F. Ming, J. W. Han, and B. A. Hemmings. 1996. Activation and phospholylation of a pleck-strin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. USA. 93: 5699-5704.
43. Burgering, B. M. T., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phopshatidylinositol-3-OH kinase signal transduction. Nature. 376: 599-602.
44. Konishi, H., H. Matsuzaki, M. Tanaka, Y. Ono, C. Tokunaga, S. Kuroda, and U. Kikkawa. 1996. Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of phosphatidylinositol 3-kinase. Proc. Natl. Acad Sci. USA. 93: 7639-7643.
45. Moule, S. K., G. I. Welsh, N. J. Edgelf, E. J. Foulstone, C. G. Proud, and R. M. Denton. 1997. Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and β-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J. Biol. Chem. 272: 7713-7719.
46. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, R. A. Copeland, R. L. Magolda, P. A. Scherle, and J. M. Trzaskos. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase. J. Biol. Chem. 273: 18623-18632.